熱門資訊> 正文
Essapeutics公开募股定价为7500万美元
2025-10-08 13:34
- Esperion Therapeutics (ESPR) is offering 30M shares of common stock at $2.50 per share in an underwritten public offering.
- The company has granted underwriters a 30-day option to purchase up to 4.5M additional shares.
- Gross proceeds are expected to be ~$75M before fees and expenses, excluding any option exercise.
- All shares are being sold by Esperion, with no secondary sales included.
- The offering is expected to close on or around October 9, 2025.
- Source: Press release
More on Esperion Therapeutics
- Esperion: A Mixture Of Opportunity And Risk: Why I Would Hold For Now
- Esperion Therapeutics, Inc. (ESPR) Presents At Cantor Global Healthcare Conference 2025 Transcript
- Esperion Therapeutics, Inc. 2025 Q2 - Results - Earnings Call Presentation
- Esperion slides after pricing $75M stock offering
- Esperion settles patent dispute with Dr. Reddy’s over cholesterol drugs
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
